MeiraGTx Holdings plc

IPO

MeiraGTx Holdings plc is a biotech company in New York, United States, founded in 2015. It has raised $220.0M across 3 rounds, most recently a $100.0M Corporate Round in April 2026.

Next-Gen Genetic Medicine - MeiraGTx

Headquarters
New York, New York
Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$220.0M
Last Round
$100.0M Corporate RoundApr 2026
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage genetic medicines company with four late-stage clinical programs targeting the eye, Parkinson's disease, and xerostomia. The company uses innovative capsid, promoter, and translational control technologies to develop potent viral vectors, supported by end-to-end in-house GMP manufacturing. MeiraGTx has also developed a proprietary riboswitch platform enabling oral small molecule control of in vivo gene expression for metabolic and oncology applications.

Summary

It lists 51–200 employees. It has raised $220.0M in total across 3 rounds, most recently a $100.0M Corporate Round in Apr 2026. Investors include Sanofi Ventures and UCL Technology Fund.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundApr 2026
$100.0M

Sign up to see all 4 events

Funding: Series B through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MeiraGTx Holdings plc on Indexed.vc
<a href="https://indexed.vc/companies/meiragtx-holdings-plc"><img src="https://indexed.vc/api/badge/company/meiragtx-holdings-plc" alt="MeiraGTx Holdings plc on Indexed.vc" width="260" height="76" /></a>